Gilead

Gilead Announces Phase 3 Results for an All-Oral, Sofosbuvir-Based Regimen for the Treatment of Hepatitis C in Patients Co-Infected With HIV
Yahoo/BusinessWire
Sat, 11/2/13 - 11:28 am
Gilead
hepatitis C
sofosbuvir
Why Gilead's Sofosbuvir Is Better Than J&J's Simeprevir
Motley Fool
Tue, 10/29/13 - 09:21 am
Gilead
sofosbuvir
JNJ
hepatitis C
simeprevir
FDA panel backs Gilead Sciences' hepatitis C drug
Yahoo/AP
Sat, 10/26/13 - 08:07 am
Gilead
FDA
advisory panels
hepatitis C
sofosbuvir
Biotech Stock Bubble Debate in 14 Charts
TheStreet.com
Wed, 10/23/13 - 08:32 am
biotech
Bluebird Bio
Celgene
Celldex
Onconova
Aegerion
Receptos
Immunomedics
Alcobra
Gilead
Biogen Idec
Ambit Biosciences
The Most Important Week of the Year Has Arrived for Gilead Sciences
Motley Fool
Wed, 10/23/13 - 08:24 am
Gilead
sofosbuvir
hepatitis C
Can Amgen Grow Faster Than Gilead Sciences and Teva Pharmaceutical?
Motley Fool
Mon, 10/21/13 - 08:37 am
Gilead
Teva
Amgen
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Cleveland Clinic
JNJ
Pharmacyclics
Novartis
serelaxin
ibrutinib
sofosbuvir
Gilead
You Shouldn't Ignore Gilead's Idelalisib
Motley Fool
Thu, 10/17/13 - 09:54 am
Gilead
idelalisab
indolent non-Hodgkin's lymphoma
MacroGenics - Cancer IPOs Remain The Hottest Thing In Town
Seeking Alpha
Mon, 10/14/13 - 09:29 am
IPOs
Macrogenics
Pfizer
Gilead
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
Does Conatus Pharmaceuticals Have A Winner With Emricasan?
Seeking Alpha
Thu, 09/26/13 - 08:12 am
Conatus Pharmaceuticals
emricasan
Gilead
Merck
Pfizer
liver disease
Sunesis
apoptosis
CHMP thumbs up for 11 new drugs
Pharma Times, UK
Mon, 09/23/13 - 09:33 am
Europe
drug approvals
Kadcyla
Roche
Bayer
Xofigo
Abilify Maintena
Otsuka
Lundbeck
Memantine Accord
Accord Healthcare
Levodopa Carbidopa Entacapone Sandoz
Orion
Vitekta
Gilead
Janssen-Cilag
Invokana
Novo Nordisk
NovoEight
AstraZeneca
Fluenz Tetra
GSK
Relvar Ellipta
Lidocaine/Prilocaine Plethora
Plethora Solutions
Gilead revenue growth likely to accelerate, says Bernstein
Yahoo/Fly on the Wall
Thu, 09/19/13 - 08:17 am
Gilead
3 Companies Racing to Transform Hepatitis-C Treatment
Motley Fool
Thu, 09/19/13 - 02:58 am
hepatitis C
Gilead
sofosbuvir
AbbVie
Bristol-Myers Squibb
daclatasvir
asunaprevir
BMS-791325
Actavis, Gilead, Valeant: Outlook For Health Stocks
Investors.com
Fri, 09/13/13 - 09:16 am
Valeant Pharmaceuticals
Actavis
Gilead
Yes, Gilead Did It Again
Seeking Alpha
Sat, 08/31/13 - 10:29 am
Gilead
sofosbuvir
Bristol Myers: A Leader In Cancer Care
Seeking Alpha
Fri, 08/30/13 - 08:46 am
Bristol-Myers Squibb
Merck
Gilead
Pfizer
Roche
Vertex Building A Fortress In Cystic Fibrosis
Investopedia
Wed, 08/28/13 - 04:41 pm
Vertex
cystic fibrosis
Gilead
GSK
Kalydeco
Bristol-Myers Squibb
Gilead's sofosbuvir cures some of the toughest hepatitis C cases
Fierce Biotech
Wed, 08/28/13 - 12:38 pm
hepatitis C
Gilead
sofosbuvir
Can This HIV Drug Challenge Gilead's Domination?
Motley Fool
Wed, 08/28/13 - 08:48 am
Gilead
HIV
ViiV Healthcare
Tivicay
GSK
Shionogi
Pfizer

Pages